INSIDER TRADING

Cluster sell at Replimune Group, Inc.: six insiders sell $2.29M of REPL

By Insider Stock Trader Newsroom, Insider Stock Trader: Alerts app1 min readInsider Stock Trader
Cluster sell at Replimune Group, Inc.: six insiders sell $2.29M of REPL

Open-market sales between Nov 2 and Nov 16, none marked as part of a 10b5-1 plan. By the Insider Stock Trader: Alerts app. Information only, not investment advice.

Form 4 filings show six Replimune Group, Inc. insiders selling stock between Nov 2 and Nov 16, for a total of $2.29 million.

The largest sale came from Sushil Patel, a CEO, who sold 49,026 shares for $1.06 million. None of these filings marks the sale as made under a Rule 10b5-1 trading plan.

Konstantinos Xynos (chief medical officer) is the latest to report, in a filing on Nov 18. The table below lists who sold, when, and at what price.

Details from the SEC filing:

Who sold when
InsiderRoleTrade dateSharesAvg. priceValueFiling
Kapil DhingraDirectorNov 221,500$19.00$408,500App · SEC
Joseph P SlatteryDirectorNov 95,200$21.80$113,360App · SEC
Emily Luisa HillCFONov 1614,709$21.60$317,714App · SEC
Sushil PatelCEONov 1649,026$21.60$1,058,962App · SEC
Andrew SchwendenmanChief Accounting OfficerNov 162,148$21.60$46,397App · SEC
Konstantinos XynosChief Medical OfficerNov 1616,198$21.60$349,877App · SEC
Total$2,294,810

See every insider trade at Replimune Group, Inc.

Each row of the table links to its Form 4 on SEC.gov.

See all the latest insider trades · See earlier insider stories on Replimune Group, Inc.

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.